Yossi Maimon, VP, Chief Financial Officer at Protalix BioTherapeutics, Inc. (PLX), sold 167,698 shares at $9.50 ($1.6M) on 2009-10-15, disclosed to the SEC on 2009-10-19.
Scheduled sale ($1.6M) by VP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 109,700 | $1.0M | 65.9% |
| 2 | $9.21 | 17,698 | $163K | 10.3% |
| 3 | $9.35 | 40,300 | $377K | 23.8% |
| Total | $9.43 avg | 167,698 | $1.6M | 100% |
| Filing → |
| PLX | SELL | 2010-10-08 | $677K | — | Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-07-08 | $255K | — | Filing → |